MUC5AC and cystic fibrosis: A search of ClinicalTrials.gov revealed no ongoing or completed trials targeting MUC5AC expression in CF, and no siRNA therapies currently in clinical trials appear to address downstream hypersecretion beyond ion transport (search conducted October 2025).